![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://news.bloomberglaw.com/health-law-and-business/gsks-viiv-sues-exavir-over-licensing-pact-on-hiv-drug-compounds?context=search&index=12
https://www.globenewswire.com/news-release/2022/06/09/2459524/0/en/Exavir-Therapeutics-announces-publication-of-preclinical-data-for-ultra-long-acting-dolutegravir-prodrug-XVIR-120.html
https://www.globenewswire.com/news-release/2022/05/23/2448266/0/en/Exavir-Therapeutics-Completes-4M-Seed-Financing-from-Key-Investors.html